Results 31 to 40 of about 170,034 (262)

Is Irisin Anticancer Agent?

open access: yesProceedings, 2018
Irisin is a protein, which is encoded by the FNDC5 gene. Irisin secreted as a hormone secret via Fibronectin type III domain-containing protein 5. Irisin is always provide beneficial effect of exercise on cellular metabolism as well as obesity and ...
Işıl Yıldırım
doaj   +1 more source

Computational fluid dynamics study of intra-arterial chemotherapy for oral cancer

open access: yesBioMedical Engineering OnLine, 2017
Background Intra-arterial chemotherapy (IAC) for oral cancer can deliver a higher concentration of anticancer agent into a tumor-feeding artery than intravenous systemic chemotherapy. However, distribution of anticancer agent into several branches of the
Hiroaki Kitajima   +6 more
doaj   +1 more source

Cytotoxicity Induced by Newly Synthesized Palladium (II) Complexes Lead to the Death of MCF-7 and MDA-MB-435 Cancer Cell Lines [PDF]

open access: yesAdvanced Pharmaceutical Bulletin, 2023
Purpose: Breast cancer is the most common female malignancy and melanoma is the most lethal type of skin cancer. Traditional therapy for cancer treatment is far from satisfactory due to drug resistance and side effects, thus a search for new medicines is
Bruna Alexandre Oliveira da Silva   +6 more
doaj   +1 more source

Onopordopicrin from the new genus Shangwua as a novel thioredoxin reductase inhibitor to induce oxidative stress-mediated tumor cell apoptosis

open access: yesJournal of Enzyme Inhibition and Medicinal Chemistry, 2021
Isolation and identification of natural products from plants is an essential approach for discovering drug candidates. Herein we report the characterization of three sesquiterpene lactones from a new genus Shangwua, e.g. onopordopicrin (ONP), C2, and C3,
Junmin Zhang   +5 more
doaj   +1 more source

Casein Kinase 2 Inhibitor, CX-4945, as a Potential Targeted Anticancer Agent in Gastric Cancer [PDF]

open access: yes, 2018
BACKGROUND/AIM: Casein kinase 2 (CK2) is involved in multiple cellular processes. Furthermore, its overexpression in several human cancers has been associated with tumor progression. In this study, we evaluated the efficacy of the CK2 inhibitor, CX-4945,
정민규   +5 more
core   +1 more source

Erlotinib hydrochloride: an anticancer agent

open access: yesActa Crystallographica Section E, 2008
In the cation of the title compound, C22H24N3O4+·Cl−, an active ingredient of the anticancer drug also known as Tarceva, the quinazoline ring system is planar within 0.044 (3) Å. The dihedral angle formed by the mean planes of
K. Ravikumar   +2 more
doaj   +1 more source

Astragaloside IV, as a potential anticancer agent

open access: yesFrontiers in Pharmacology, 2023
Cancer is a global intractable disease, and its morbidity and mortality are increasing year by year in developing countries. Surgery and chemotherapy are often used to treat cancer, but they result in unsatisfactory outcomes, such as severe side effects ...
Dongqin Xia   +3 more
doaj   +1 more source

Isolation and Structure Determination of a New Lumichrome Glycoside Isolated from a Soil sp. KCB16C001

open access: yesNatural Product Communications, 2018
Microbial studies of soil samples collected at Ochang, Korea led to the isolation of the actinobacterium Streptomyces sp. KCB16C001. Subsequent LC/MS analysis of the culture extract for dereplication purposes enabled the identification of a new ...
Sangkeun Son   +8 more
doaj   +1 more source

Toxicity and Anticancer Potential of Karwinskia: A Review

open access: yesMolecules, 2020
Karwinskia genus consists of shrubs and small trees. Four toxic compounds have been isolated from Karwinskia plants, which were typified as dimeric anthracenones and named T496, T514, T516, and T544. Moreover, several related compounds have been isolated
Gilberto Jaramillo-Rangel   +3 more
doaj   +1 more source

Repurposing Tranexamic Acid as an Anticancer Agent

open access: yesFrontiers in Pharmacology, 2022
Tranexamic Acid (TA) is a clinically used antifibrinolytic agent that acts as a Lys mimetic to block binding of Plasminogen with Plasminogen activators, preventing conversion of Plasminogen to its proteolytically activated form, Plasmin. Previous studies
Mary E. Law   +14 more
doaj   +1 more source

Home - About - Disclaimer - Privacy